|
Volumn 38, Issue 4, 2002, Pages 401-404
|
Ivermectin is better than benzyl benzoate for childhood scabies in developing countries
|
Author keywords
Benzyl benzoate; Developing countries; Ivermectin; Scabies; Vanuatu
|
Indexed keywords
BENZYL BENZOATE;
CLOXACILLIN;
IVERMECTIN;
ADOLESCENT;
ARTICLE;
CELLULITIS;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DERMATITIS;
DEVELOPING COUNTRY;
DRUG EFFECT;
DRUG EFFICACY;
FOLLOW UP;
HUMAN;
INFANT;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
SCABIES;
SKIN MANIFESTATION;
TREATMENT OUTCOME;
VISUAL ANALOG SCALE;
WORM;
ADOLESCENT;
BENZOATES;
CHILD;
CHILD, PRESCHOOL;
COST-BENEFIT ANALYSIS;
DEVELOPING COUNTRIES;
DOUBLE-BLIND METHOD;
HUMANS;
INFANT;
INSECTICIDES;
IVERMECTIN;
SCABIES;
VANUATU;
|
EID: 0036039345
PISSN: 10344810
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1440-1754.2002.00015.x Document Type: Article |
Times cited : (72)
|
References (20)
|